384 related articles for article (PubMed ID: 16598680)
1. The efficacy of an antiseptic and microbial anti-adhesive ear cleanser in dogs with otitis externa.
Rème CA; Pin D; Collinot C; Cadiergues MC; Joyce JA; Fontaine J
Vet Ther; 2006; 7(1):15-26. PubMed ID: 16598680
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an ear cleanser for the treatment of infectious otitis externa in dogs.
Cole LK; Kwochka KW; Kowalski JJ; Hillier A; Hoshaw-Woodard SL
Vet Ther; 2003; 4(1):12-23. PubMed ID: 12756632
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa.
Rougier S; Borell D; Pheulpin S; Woehrlé F; Boisramé B
Vet Dermatol; 2005 Oct; 16(5):299-307. PubMed ID: 16238809
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of an ear rinse containing tromethamine, EDTA, benzyl alcohol and 0.1% ketoconazole on Malassezia organisms from dogs with otitis externa.
Cole LK; Luu DH; Rajala-Schultz PJ; Meadows C; Torres AH
Vet Dermatol; 2007 Apr; 18(2):115-9. PubMed ID: 17355426
[TBL] [Abstract][Full Text] [Related]
5. Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa.
Lyskova P; Vydrzalova M; Mazurova J
J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):559-63. PubMed ID: 18045339
[TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled trial of the efficacy and safety of a terbinafine, florfenicol and betamethasone topical ear formulation in dogs for the treatment of bacterial and/or fungal otitis externa.
Forster SL; Real T; Doucette KP; King SB
BMC Vet Res; 2018 Aug; 14(1):262. PubMed ID: 30170597
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bacterial organisms and their susceptibility patterns from otic exudate and ear tissue from the vertical ear canal of dogs undergoing a total ear canal ablation.
Cole LK; Kwochka KW; Hillier A; Kowalski JJ; Smeak DD
Vet Ther; 2005; 6(3):252-9. PubMed ID: 16299671
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa.
Cole LK; Kwochka KW; Hillier A; Kowalski JJ; Smeak DD; Kelbick NT
Vet Dermatol; 2006 Apr; 17(2):128-33. PubMed ID: 16515655
[TBL] [Abstract][Full Text] [Related]
9. [In-vivo efficacy of a commercial ear antiseptic containing chlorhexidine and Tris-EDTA. A randomised, placebo-controlled, double-blinded comparative trial].
Bouassiba C; Osthold W; Mueller RS
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(3):161-70. PubMed ID: 22688793
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of boric-complexed zinc and acetic-complexed zinc otic preparations for canine yeast otitis externa.
Mendelsohn CL; Griffin CE; Rosenkrantz WS; Brown LD; Boord MJ
J Am Anim Hosp Assoc; 2005; 41(1):12-21. PubMed ID: 15634862
[TBL] [Abstract][Full Text] [Related]
11. Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.
Cole LK; Papich MG; Kwochka KW; Hillier A; Smeak DD; Lehman AM
Vet Dermatol; 2009 Feb; 20(1):51-9. PubMed ID: 19152587
[TBL] [Abstract][Full Text] [Related]
12. Microbial flora and antimicrobial susceptibility patterns of isolated pathogens from the horizontal ear canal and middle ear in dogs with otitis media.
Cole LK; Kwochka KW; Kowalski JJ; Hillier A
J Am Vet Med Assoc; 1998 Feb; 212(4):534-8. PubMed ID: 9491161
[TBL] [Abstract][Full Text] [Related]
13. Comparison of microbial isolates and susceptibility patterns from the external ear canal of dogs with otitis externa.
Graham-Mize CA; Rosser EJ
J Am Anim Hosp Assoc; 2004; 40(2):102-8. PubMed ID: 15007044
[TBL] [Abstract][Full Text] [Related]
14. Morphologic measurements of the external horizontal ear canal of dogs.
Stout-Graham M; Kainer RA; Whalen LR; Macy DW
Am J Vet Res; 1990 Jul; 51(7):990-4. PubMed ID: 2389897
[TBL] [Abstract][Full Text] [Related]
15. Wound contamination and antimicrobial susceptibility of bacteria cultured during total ear canal ablation and lateral bulla osteotomy in dogs.
Vogel PL; Komtebedde J; Hirsh DC; Kass PH
J Am Vet Med Assoc; 1999 Jun; 214(11):1641-3. PubMed ID: 10363095
[TBL] [Abstract][Full Text] [Related]
16. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of 0.1% tacrolimus solution applied to the external ear canals of atopic beagle dogs without otitis.
Kelley LS; Flynn-Lurie AK; House RA; Simpson AC; Marsella R
Vet Dermatol; 2010 Dec; 21(6):554-65. PubMed ID: 20609208
[TBL] [Abstract][Full Text] [Related]
18. Histological changes in the external ear canal of dogs with otitis externa.
Huang HP; Little CJ; McNeil PE
Vet Dermatol; 2009 Oct; 20(5-6):422-8. PubMed ID: 20178479
[TBL] [Abstract][Full Text] [Related]
19. Total ear canal ablation combining bulla osteotomy and curettage in dogs with chronic otitis externa and media.
Beckman SL; Henry WB; Cechner P
J Am Vet Med Assoc; 1990 Jan; 196(1):84-90. PubMed ID: 2295558
[TBL] [Abstract][Full Text] [Related]
20. [Microbiological results of ear swabs from dogs and cats].
Müller E; Heusinger A
Tierarztl Prax; 1994 Feb; 22(1):80-4. PubMed ID: 8165666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
